Fluorescence diagnosis and photodynamic therapy in dermatology from experimental state to clinic standard methods

Journal of Environmental Pathology, Toxicology and Oncology

Volumn 25, Issue 1-2, 2006, Pages 425-439

  Fritsch, Clemens ^a,b   Ruzicka, Thomas ^b  

^a Private Clinic   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

ALA; FD; Fluorescence diagnosis; MAL; MAOP; PDT; Photodynamic therapy; Porphyrins

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BETAMETHASONE VALERATE; FUCICORT; FUSIDIC ACID; IMIQUIMOD; OCTENIDINE; OCTENISEPT; PHOTOSENSITIZING AGENT; PORPHYRIN; UNCLASSIFIED DRUG;

ACNE VULGARIS; ACTINIC KERATOSIS; ARTICLE; BASAL CELL CARCINOMA; CANCER CELL; CARCINOMA IN SITU; CHEILITIS; DIAGNOSTIC PROCEDURE; DRUG EFFICACY; EPITHELIUM TUMOR; FEVER; FLUORESCENCE; HUMAN; INFLAMMATION; LIGHT; LYMPHADENOPATHY; PAIN; PHOTODYNAMIC THERAPY; PHOTODYNAMICS; PRIORITY JOURNAL; SKIN CANCER; SKIN SENSITIZATION; SKIN TUMOR; SWELLING; VIRUS INFECTION;

EID: 33644785025     PISSN: 07318898     EISSN: None     Source Type: Journal    
DOI: 10.1615/jenvironpatholtoxicoloncol.v25.i1-2.270     Document Type: Article

References (18)

1. Moan J, Peng Q. An outline of the hundred-year history of PDT. (Review). Anticancer Res 2003; 23:3591-3600.
2. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B 1990; 6:143-148.
3. Fritsch C, Ruzicka T. Fluorescence Diagnosis and Photodynamic Therapy of Skin Diseases. Atlas and Handbook. New York: Springer; 2003.
4. Peng Q, Moan J, Warloe T, Iani V, Steen HB, Bjorseth A, Nesland JM. Build up of esterified aminolevulinic-acid-derivative-induced porphyrin fluorescence in normal mouse skin. J Photochem Photobiol B 1996; 34:95-96.
5. Soler AM, Warloe T, Berner A, Giercksky KE. A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage. Br J Dermatol 2001; 145:467-471.
6. Wennberg AM, Wulf HC, Warloe T. Metvix® photodynamic therapy in patients with basal cell carcinoma at risk of complications and poor cosmetic outcome after conventional therapy. J Eur Acad Dermatol Venereol 2000; 15(S2):225.
7. Horn M, Wolf P, Wulf HC, Warloe T, Fritsch C, Rhodes LE, Kaufmann R, De Rie M, Legat FJ, Stender IM, Soler AM, Wennberg AM, Wong GA, Larko O. Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment. Br J Dermatol. 2003; 149:1242-1249.
8. Basset-Seguin N, Ibbotson S, Emtestam L. Photodynamic therapy using Metvix® is as efficacious as cryotherapy in BCC, with better cosmetic results. J Eur Acad Dermatol Venereol 2001; 15(S2):226.
9. Policard A. Etude sur les aspects offerts par des tumeurs expérimentales examinées à la lumière de Wood. C R Soc Biol 1924; 91:1423-1424.
10. Fritsch C, Homey B, Stahl W, Lehmann P, Ruzicka T, Sies H. Preferential relative porphyrin enrichment in solar keratoses upon topical application of delta-aminolevulinic acid methylester. Photochem Photobiol 1998; 68:218-221.
11. Klotz LO, Fritsch C, Briviba K, Tsacmacidis N, Schliess F, Sies H. Activation of JNK and p38 but not ERK MAP kinases in human skin cells by 5-aminolevulinate-photodynamic therapy. Cancer Res 1998; 58:4297-4300.
12. Dellian M, Abels C, Kuhnle GE, Goetz AE. Effects of photodynamic therapy on leucocyte-endothelium interaction: differences between normal and tumour tissue. Br J Cancer 1995; 72:1125-1130.
13. Fritsch C, Ruzicka T, Goerz G. Photodynamic therapy in dermatology. Arch Dermatol 1998; 134:207-214.
14. Szeimies RM, Abels C, Fritsch C, Karrer S, Steinbach P, Baumler W, Goerz G, Goetz AE, Landthaler M. Wavelength dependency of photodynamic effects after sensitization with 5-aminolevulinic acid in vitro and in vivo. J Invest Dermatol 1995; 105:672-677.
15. Freeman M, Vinciullo C, Francis D. A comparison of photodynamic therapy using topical methyl 5 amino-levulinate (Metvix®) with single cell cryotherapy in patients with actinic keratosis: a prospective randomised study. J Dermatol Treat 2003; 14:99-106.
16. Szeimies RM, Karrer S, Radakovic-Fijan S, Tanew A, Calzavara-Pinton PG, Zane C, Sidoroff A, Hempel M, Ulrich J, Proebstle T, Meffert H, Mulder M, Salomon D, Dittmar HC, Bauer JW, Kernland K, Braathen L. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study. J Am Acad Dermatol 2002; 47:258-262.
17. Szeimies RM, Gerritsen MJ, Gupta G, Ortonne JP, Serresi S, Bichel J, Lee JH, Fox TL, Alomar A. Imiquimod 5% cream for the treatment of actinic keratosis: results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology. J Am Acad Dermatol 2004; 51:547-555.
18. Rhodes L, de Rie M, Engtrom Y. A randomized comparison of excision surgery and PDT using methyl aminolevulinate in nodular basal cell carcinoma. Ann Dermatol Venereol 2002; 129(S1):1S108.